Regulatory Strategies for Dx-Rx Approvals for Gene Therapies & Impact of Marketing Requirements
- Current regulatory challenges for Dx-Rx co-development in GT
- Strategies for approval for GT diagnostics
- EU and US payer’s policies impact on regulatory decision making in GT diagnostics